¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2023-11-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2023-11-10
±³À°ÀÏÀÚ : 2023-11-10
±³À°Àå¼Ò : °¡Å縯´ëÇб³ Omnibus Park convention hall

±³À°ÁÖÁ¦ : 2023³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸  

´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540

À̸ÞÀÏ : kalc@lungca.or.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í »çÀüµî·Ï ȸ¿ø: 50,000¿ø/ ºñȸ¿ø 70,000¿ø ÇöÀåµî·Ï ȸ¿ø: 60,000¿ø/ ºñȸ¿ø 80,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 09:00~09:20 Immunologic perspective of immune cold tumor non-squamous vs squamous Yoon Park(KIST)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 09:20~09:40 Clinical categories of cold tumor among lung cancer: Genetic correlations Hyo Sup Shim(Yonsei University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 09:40~10:00 Vaccine and non-vaccine strategy to convert cold to hot tumors vaccine and conceptual therapeutics (ADC, bispecific, myeloid targeting) Beung-Chul Ahn(National Cancer Center)

Åä·Ð 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 10:00~10:20 Q&A ()

ÈÞ½Ä 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 10:20~10:40 Coffee Break ()

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 10:40~11:00 SCLC subtypes and implication to immunotherapy Sehhoon Park(Sungkyunkwan University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 11:00~11:20 Immune checkpoint inhibitors for SCLC Jang Ho Cho(Catholic University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 11:20~11:40 Novel antibody therapeutics for SCLC Tae Min Kim(Seoul National University)

Åä·Ð 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 11:40~12:00 Q&A ()

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 12:00~12:40 Perioperative chemo-immunotherapy for resectable NSCLC Teru-Fumi Kato (Kanagawa Cancer Center)

ÈÞ½Ä 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 12:40~13:00 Coffee Break ()

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 13:00~13:20 Resectability should be changed with neoadjuvant chemo-immunotherapy? Samina park(Seoul National University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 13:20~13:40 Promising result and future challenges for perioperative chemo-immunotherapy Gyeong-Won Lee(Gyeongsang National University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 13:40~14:00 Biomarker analysis of perioperative chemo-immunotherapy Si-Hyong Jang(Soonchunhyang University)

Åä·Ð 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 14:00~14:20 Q&A ()

ÈÞ½Ä 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 14:20~14:40 Coffee Break ()

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 14:40~15:00 Benefit and limitations of IO in mesothelioma Nivo+Ipi, CAR-T Hee Kyung Ahn (Gachon University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 15:00~15:20 Heterogeneity and its implications in IO for thymic malignancies Sunhee Chang(Inje University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 15:20~15:40 Novel immunotherapeutics for thoracic malignancies specific ADC, bispecific data Sun Min Lim(Yonsei University)

Åä·Ð 11¿ù 10ÀÏ 15:40~16:00 Q&A ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2023-11-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ³×Æ®¿öÅ©¸ÞŸºÐ¼®À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2023-11-10
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ê GPT ½Ã´ë, ÀÇ·á ÀΰøÁö´É°ú ÀÇ»çÀÇ ¿ªÇÒ : 2023-11-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
120 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø 2018³â È£½ºÇǽºÀÇ·á±â°ü Á¾»çÀÚ º¸¼ö±³À°°úÁ¤ : 2018-08-25 0 1,437 2018-07-28
119 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ±³À°ÀÚ ¼¼¹Ì³ª : 2018-08-25 0 666 2018-07-28
118 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease(Day 1) : 2018-08-25 0 578 2018-07-28
117 ´ëÀü ´ëÇѳëÀκ´ÇÐȸ ³ëÀÎȯÀÚÀÇ Ä¡·á¿Í º¯È­ÇÏ´Â ÀÇ·á : 2018-08-25 0 1,182 2018-07-28
116 ºÎ»ê 2018³â ´ëÇÑÁßȯÀÚÀÇÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ NIV ¿öÅ©¼¥ : 2018-08-25 0 892 2018-07-28
115 ÀÎõ 2018³â ´ëÇѺҾÈÀÇÇÐȸ Çϰ迬¼ö±³À° : 2018-08-25 0 619 2018-07-28
114 ¼­¿ï Çѱ¹¿©ÀÚÀÇ»çȸ ¿°Áõ¼º Àå Áúȯ Áø´Ü°ú Ä¡·á / ³»½Ã°æ ¹ßÀü ¿ª»ç : 2018-08-25 0 539 2018-07-28
113 ´ë±¸ ´ëÇѵÎÅëÇÐȸ ´ë±¸, °æºÏÁö¿ª º¸¼ö±³À°(¸¸¼ºÆíµÎÅë Áø´Ü ¹× Ä¡·á 6 ´Ü°è) : 2018-08-25 0 757 2018-07-28
112 °æ±â Á¦ 7ȸ ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-08-25 0 611 2018-07-28
111 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó ¿ÀÀü session(8.25) : 2018-08-25 0 998 2018-07-28
110 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó Interactive workshop(8.25) : 2018-08-25 0 700 2018-07-28
109 ±¤ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦99Â÷ Àü³²ºÏÁöȸ ¿¬¼ö°­Á : 2018-08-25 0 621 2018-07-28
108 ºÎ»ê ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ East Asian Conference of Neurointervention 2018 : 2018-08-25 0 255 2018-07-28
107 ¼­¿ï 2018³â Á¦11ȸ ¼­¿ï´ëÇб³º´¿ø ÀçÈ°ÀÇÇаú ¿¬¼ö°­Á : 2018-08-25 0 542 2018-07-28
106 ¼­¿ï 2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/25) : 2018-08-25 0 267 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷